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We summarize a recently developed microtechnology for printing biomaterials on
biological surfaces. The technique is based on the use of immiscible aqueous so-
lutions of two biopolymers and allows spatially defined placement of cells and
biomolecules suspended in the denser aqueous phase on existing cell layers and
extracellular matrix hydrogel surfaces maintained in the second phase. Printing
takes place due to an extremely small interfacial tension and density difference
between the two aqueous phases. The contact-free printing process ensures that
both printed cells and the underlying cell monolayer maintain full viability and
functionality. The technique accommodates both arbitrarily shaped patterns and
microarrays of cells and bioreagents. The capability to print cells and small mol-
ecules on existing cell layers enables unique interrogations of the effects of cell-cell
and cell-material interaction on cell fate and function. Furthermore, the very gentle
conditions and the ability to directly pattern nongel embedded cells over cells make
this technology appealing to tissue engineering applications where patterned mul-
ticellar organization with minimal scaffolding materials is needed, such as in dense
tissues of the skeletal muscle and liver. © 2011 American Institute of
Physics. doi:10.1063/1.3516658
I. INTRODUCTION
Organ failure as a result of injury or disease affects the quality of life of millions of people
worldwide. The past two decades have witnessed extensive research dedicated to the development
of new strategies for restoring or creating new tissue constructs.1 Several approaches have resulted
in the delivery of isolated cells to replace lost cells and restore the tissue function, the use of
tissue-inducing factors such as growth- and differentiation-inducing molecules to a target site, and
constructing tissue pieces in vitro using cells, hydrogels, and other factors as the building blocks.1
While the first two techniques yield promising results for small defects, extensive tissue damage in
majority of patients leaves the last method as the only viable option.
Two major approaches have been developed for in vitro engineering of artificial tissue re-
placements: “top-down” and “bottom-up.”2 The former involves the fabrication of a porous scaf-
fold of synthetic polymers e.g., polyglycolide, polylactide, and polylactide coglycolide and natu-
ral materials e.g., fibrin and collagen and subsequent injection of a cocktail of one or more cell
types of the target tissue. The scaffold, which may also be chemically conjugated to various
aPresent address: 260 South Forge Street, Olson Research Center, Akron, OH 44325, USA. Electronic mail:
tavana@uakron.edu. Tel.: 330 972-6031.
bPresent address: 2200 Bonisteel Blvd., Ann Arbor, MI 48109-2099, USA, Electronic mail: takayama@umich.edu. Tel.:
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biomolecules, provides growth promoting cues to cells and guides their synthesis of extracellular
matrix ECM proteins and other factors.3–5 The physicochemical and geometrical properties of
the scaffold and the intrinsic propensity of cells to organize into three-dimensional structures are
key determinants of the quality of tissue formation.6,7 This approach has shown some promise;8,9
nevertheless, there are several drawbacks inherent to the scaffold-based tissue engineering includ-
ing nonuniform distribution of cells within the scaffold, lack of control over spatial placement of
different cell types in a prearranged manner, and interference of the scaffold with direct cell-cell
interactions. These can result in insufficient cellular organization and impaired formation and
function of the construct. In addition, the scaffolding material may elicit adverse host responses.
The bottom-up approach can, in principle, overcome these limitations and accommodate
placement of defined densities of various cell types and natural ECM materials in a spatially
controlled manner to allow direct cell-cell and cell-ECM contact. The assembly of cell-laden
microgels in two-phase media driven by energetic effects,2 printing of cell-loaded hydrogels
through mechanical valves and needles,10–12 assembly of cellular spheroids onto templating aga-
rose rods,13 rapid prototyping-based matrix fabrication,14,15 micromolding of cells and
hydrogels,16 inkjet printing of cells onto hydrogels,17,18 and cell sheet engineering19–21 are major
methods developed to control three-dimensional tissue structuring. Although the majority of these
techniques are still in the research phase, the cell sheet engineering technology has already been
successfully utilized in clinical settings for reconstruction of thin corneal tissue.22
For a bottom-up patterning/printing approach to be useful for tissue engineering applications,
a series of criteria should be met. The method should i be gentle to cells and avoid exerting large
forces during preparation and patterning steps so that cells retain high viability and full function-
ality, ii be noncontact to allow placement of particulates on already existing cell layers, iii
enable layered spatial patterning of multiple cell types specific to a tissue, iv be carried out in
fully aqueous cell-friendly media to prevent drying or stressing of cells, v ensure fidelity of
patterned/printed biomaterials including cells, hydrogels, and small molecules, and vi avoid
exposure to harmful mutation-inducing radiations e.g., ultraviolet light that may be used for
cross-linking of hydrogels. Recently, we have developed a simple and efficient method for pat-
terning biomolecules and layering of cells on living cell layers that meets these criteria. In the
following, we summarize this approach and highlight its potential as a new tissue engineering
technique.
II. DIRECT MICROPRINTING ON CELLS USING AQUEOUS TWO-PHASE SYSTEMS
Aqueous mixtures of several polymers above certain concentrations segregate and give rise to
two distinct phases.23 The resulting system is known as an aqueous two-phase system ATPS and
is characterized by a unique phase diagram, which describes the composition of each phase and
the range of concentrations that result in phase separation Fig. 1. To form an ATPS, the polymers
can first be dissolved separately in aqueous media at desired polymer concentrations e.g., point A
in Fig. 1. The two solutions are then thoroughly mixed and allowed to equilibrate. A sharp
interface is formed after the equilibrium condition is established and two distinct phases with
compositions of points B and C form Fig. 1. Then, the two phases can be separated gently. This
principle has been used in various macroscale bioseparation processes as a means of purifying
biological particulates, including proteins and cells, based on the physicochemical properties of
the phase forming polymers and biomolecules of ineterest.24,25 ATPSs have also been used as
microscale separation media to partition cells and proteins in microfluidic devices.26,27 The non-
ionic polymers polyethylene glycol PEG and dextran DEX are most widely used in such
applications and provide a mild bioseparation environment and act as the protectant of the
particulates.25 This particular ATPS always gives rise to a top PEG phase and a bottom DEX phase
due to a small density difference between them.
We have recently adapted this partitioning technology to develop a novel approach for direct
contact-free printing of bioreagents on cell layers. The aqueous PEG phase prepared in culture
media is used as the immersion phase to cover a monolayer of cells in culture. The DEX phase is
used as the patterning phase and is loaded into a patterning tool such as an extruded pipette tip.
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The pipette tip is lowered in the vicinity of the cell layer. The denser DEX phase immediately
dispenses out of the tip of the pipette to form a droplet. However, the extremely small interfacial
tension between the two aqueous phases, usually of the order of 1–100 J /m2, cannot support
the weight of the drop, and thus, the DEX phase dispenses continuously. This autonomous dis-
pensing combined with simultaneous horizontal movement of the patterning tool results in the
formation of a linear pattern of the DEX phase on the cell monolayer maintained in the aqueous
PEG phase Figs. 2a and 2b.28 The ultralow PEG-DEX interfacial tension combined with the
microscale roughness of the cell monolayer and the affinity of cell’s surface to the DEX phase help
FIG. 1. Polymeric ATPS. A typical phase diagram of an ATPS comprising PEG Mw: 8 K and DEX Mw: 500 K. Only
those combinations of the two polymers P PEG and Q DEX above the binodal curve give an ATPS. Point A represents
the initial concentration of each polymer in the entire solution, whereas points B and C describe the compositions of
bottom and top phases in equilibrium, respectively. Line BC represents a tie line and is a unique property of the given
ATPS.
FIG. 2. Reagent microprinting on cells. a The denser DEX phase is used as the patterning phase and printed on cells
immersed in the PEG phase. b The ATPS microprinting technique allows generating user-defined stable patterns of
reagents on cells. c Long-term stability of patterns is demonstrated by including liposomal transfection complexes of a
dsRed plasmid in the patterning DEX phase and printing them in the shape of a diamond. The resulting gene expression
pattern resembles the printed diamond shape. Scale bar 1 mm in b and c. Panels b and c adapted with permission
from NPG Ref. 28.
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maintain the DEX phase patterns stable over extended periods of time at least a day. Further-
more, bioreagents can be stably partitioned in the DEX phase and thus be localized for durations
that are far beyond what can be expected if there was free diffusion of reagents and that are
sufficient for bioreagents to exert their function. We confirmed this point, for example, by printing
transfection complexes of nucleic acids dsRed on a monolayer of cells in an arbitrary shape.
Cells were incubated for 8 h in the presence of ATPS media, which was then washed out, and the
incubation continued for another 48 h with regular growth media to allow expression of the gene.
This resulted in localized expression patterns of the gene that exactly mimicked the shape of the
printed reagent Fig. 2c.28 Thus, the ATPS microprinting technique enabled direct, gentle,
contact-free, and stable spatial patterning of reagents on living cell monolayers in fully aqueous
cell-friendly media. The resolution of printed patterns, that is, how much the patterned DEX phase
spreads on the cell layer covered in the PEG phase, is determined by a force balance between the
three interfacial tensions, i.e., PEG phase-cell monolayer PEG-cell, DEX phase-cell monolayer
DEX-cell, and PEG phase-DEX phase PEG-DEX, where the three phases meet as well as the
diameter and volume of the dispensing mechanism.28 With an extruded pipette tip of 150 m in
diameter, patterns as thin as 300 m could be generated. Better resolutions on the scale of a few
cells may be achievable using dispensing mechanisms of a few nanoliters in volume.
We have also evaluated the compatibility of the ATPS media with cells. Marinating cells in
PEG- and DEX-containing culture media for 24 h as well as transfection of cells in ATPS media
resulted in a high viability of over 95%, similar to that observed in control experiments without
any polymer addition to media.28 It should be noted that our PEG-media is formulated with low
concentrations of a high molecular weight PEG to minimize adverse cellular effects. As with any
new media formulation, however, it may be important to verify compatibility when working with
different cell types due to variability of culture condition requirements.
III. CELL MICROPRINTING ON CELLS
The ATPS microprinting strategy can be used as a new contact-free cell printing technique
when the patterning DEX phase contains a suspension of cells. The utility of aqueous biphasic
systems for cell printing strongly depends on the partitioning behavior of cells in ATPS; that is,
which phase cells favor during the equilibration stage. The partition of cells in an ATPS depends
on the surface properties of cells and several phase factors including polymer molecular weight,
ionic composition of phases, temperature, and electrostatic potential difference and the interfacial
tension between phases.29 Elucidating the individual effect of each phase factor is often difficult
because varying one physical property can alter others too. However, it has been shown that cell
partition in ATPSs is a function of the interfacial tension between the top and bottom phases, 12,
and the electrostatic potential difference between the two aqueous phases,  i.e., K
= f12,.
30 Here K denotes the partition coefficient and is defined as the ratio of the number
of cells in the bottom and top phases, respectively.31 When both phases are prepared in the same
culture media, the effect of the electrostatic potential can safely be ignored if the phase forming
polymers are nonionic, such as PEG and DEX, and do not further contribute to the electrostatic
potential of the phases. Thus, the partition of cells becomes mainly a function of the interfacial
tension i.e., K= f12. Under this condition, it was shown that partition coefficient follows the
relation below,30
− log K  12,
where  is a constant number. For the purpose of cell printing with the PEG-DEX two-phase
system, cells should have favorable partitioning to the DEX phase i.e., the patterning medium.
According to the above equation for the K value to increase, the interfacial tension, 12, should be
minimized. The interfacial tension of aqueous biphasic systems is a function of the concentration
of the phase forming polymers and for a given ATPS, it decreases by lowering the polymer
concentrations.32 Decreasing 12 also helps maintain physiologic levels of the tonicity of the
phases and ensures that cells retain their normal morphology and function. We studied several
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two-phase systems and, based on independent measurements of the PEG-DEX interfacial tension
and the partition coefficient, identified that the ATPS with 2.5%w/w PEG Mw of 35 K and
3.2%w/w DEX Mw of 500 K gives an extremely small interfacial tension of 12=10 J /m2 and
a partition coefficient of K=78%.31 We used this system for cell printing on a cell monolayer and
found that it results in uniform patterns of printed cells confirming the above principle about the
relation between cell partition in ATPS and the interfacial tension Fig. 3a. Importantly, the
ultralow interfacial tension-driven dispensing of the patterning aqueous phase is a real advantage
over existing printing techniques that use damaging electrical and thermal energy or mechanical
means to eject biomaterials. Using the ATPS microprinting approach, cells retain a full postprint-
ing viability of 100% Fig. 3b. We have also adapted the technique to multiplexed microarray
printing of cells both on hydrogel surfaces and cell layers. A series of nanoliter-volume dispensing
pins residing on a fixture is loaded with the patterning DEX phase containing cells. The vertical
movement of the pins, which is controlled using a micromanipulator, into the PEG phase results in
the dispensing of the DEX phase and formation of droplets of cell suspension and subsequent
attachment of cells to the underlying surface Figs. 3c and 3d.
IV. APPLICATIONS TOWARD TISSUE ENGINEERING
Homotypic and heterotypic cell-cell interactions are known to have important regulatory
effects on tissue formation and function.33 For example, embryonic fibroblast-endothelial cell
interactions were shown to regulate vascularization of the engineered skeletal muscle and enhance
FIG. 3. Microprinting cells. a Green fluorescing cells printed on a monolayer of red fluorescing cells spelling “e.” b
Printed cells retain a viability of 100%. c A duplex microarray of green and red fluorescent cells printed on a layer of
porcine gel. d A microarray of green fluorescent cells printed on a monolayer of red fluorescent cells. Scale bar, 1 mm in
a, 400 m in b, and 800 m in c and d. Panels a–c adapted with permission from Wiley-VCH Ref. 31.
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the integrity of the resulting capillaries.8 Thus, the capability of direct printing of cells on living
cell layers using the ATPS approach is an enabling tool for tissue engineering type applications.
Over the past decade, there has been a growing interest in using stem cells as the cell source
for engineering tissue constructs because of the potential of these cells to differentiate into various
cell types of the body.34 The success of this approach depends on the ability to generate well-
defined niche conditions, including cell-cell, cell-ECM, and cell-soluble factors interactions, and
study the effect of these factors in directing stem cells’ fate decisions. The ATPS microprinting
technique is a potent method to interrogate the influence of niche conditions on the fate of stem
cells because it allows placement of cells on cell layers and ECM hydrogel surfaces and, in
principle, can accommodate spatial control over localized delivery of biomolecules such as growth
and differentiation factors to cells. We have conducted a series of cell and reagent printing studies
to demonstrate this point. i Mouse embryonic stem cells mESCs were directly printed on a
layer of support PA6 stromal cells to study direct heterocellular interactions effect on the differ-
entiation of mESC to neurons. Selecting the printed mESC densities in the range of 20–500 cells
per spot generated four different niche conditions. After 8 days of culture, mESCs grew to indi-
vidual colonies of 0.9–5.8 mm2. Immunostaining of mESC for neuron-specific tubulin TuJ re-
vealed neuronal differentiation of mESC at the periphery of colonies and a niche size-dependent
differentiation phenotype where larger mESC colonies yielded higher levels of TuJ expression
Figs. 4a and 4b.31 This enhanced differentiation is not simply due to higher number of cells
in larger colonies because normalizing the TuJ staining at the periphery of colonies with respect to
the area of each colony still yielded an increasing trend with colony size.31 ii An array of two
different types of feeder cells, mouse embryonic fibroblast MEF and PA6 cells, was printed on a
porcine gel coated culture plate and overlaid with mESC.35 This created duplex heterocellular
microarray of stem cell niches on a hydrogel surface. The MEF cell islands supported prolonged
undifferentiated state of mESCs, whereas PA6 cells guided differentiation of mESCs to neurons.
Interestingly on differentiation-inducing PA6 feeder cells, mESCs that grew to several small
100–300 m in diameter and interspaced 50–150 m colonies show very dense networks of
neurons. This configuration resulted in one to two orders of magnitude enhancement in the dif-
ferentiation efficiency compared to individual mESC colonies Fig. 4c.31 Computational mod-
eling suggested that observed differentiation patterns are due in part to the maintenance of con-
centration gradients of autocrine factors in the spacing among the colonies. iii As an example of
localized delivery of small molecules, liposomal complexes of nucleic acids usually smaller than
100 nm36 were printed on defined clusters of cells from a monolayer of HEK293H cells. We
obtained a multiplexed gene expression microarray for eGFP top row, dsRed bottom row, or
cotransfection of both genes middle row within a lawn of nontransfected cells Fig. 4d. The
absence of cross-contamination between the transfected cell clusters confirmed the confinement of
genetic materials to the printed DEX phase droplets during the transfection period.28 Furthermore,
other biomaterials including lentiviral vectors28 and suspensions of bacterial colonies37 have suc-
cessfully been patterned. Altogether, these studies provide ample evidence that the ATPS micro-
printing is a versatile approach for spatially defined printing of biomaterials on delicate cell and
ECM hydrogel surfaces.
V. CONCLUSION
We summarized a new microtechnology that utilizes two immiscible aqueous solutions to
print biomaterials on various substrates. This strategy offers direct and contact-free placement of
predefined patterns of cells and reagents on living cell monolayers. The printing process is ex-
tremely gentle to cells and carried out in fully aqueous cell-compatible media to accommodate full
cell viability. These features make it an appealing technology for bottom-up tissue engineering
applications. Interfacing this ATPS microprinting with robotic systems will facilitate automated
layered printing of cells and hydrogels and enable constructing tissues using the required materi-
als. This approach may help address the long-recognized challenge of constructing thick tissues of
the skeletal muscle, liver, and heart that are multicellular, contain minimal scaffolding matrix
within a dense mass of the cells, and are highly organized into three-dimensional architectures that
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FIG. 4. ATPS Microprinting for cell fate and function. a Size-dependent neuronal differentiation of individual mESC
colonies resulting from printing different densities of mESC on feeder PA6 cells. b High magnification image of lower
left corner of the third largest colony of panel a. c Enhanced differentiation of interspaced small mESC colonies on a
PA6 feeder island. d Multiplexed genetic materials printing on HEK293H cell clusters from a monolayer results in a
spatially defined gene expression pattern. The concentration of GFP and dsRed plasmids in the clusters of the middle row
is each half of that in the top and bottom rows. Scale bar 500 m in a, 100 m in b, 250 m in c, and 700 m in
d. Panel d adapted with permission from NPG Ref. 28.
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serve tissue function.38,39 The capability of organized placement of a particular cell type within a
matrix of a second cell type using the ATPS microprinting may result in more efficient construc-
tion of organized tissue structures and faster tissue vascularization compared to scaffold-based
methods, which rely on random seeding of cells. Nevertheless, a key challenge will be ensuring
that cells embedded within previously printed layers of cells remain viable and functional. A
combination of ATPS microprinting technology and other tissue engineering approaches may be
required to tackle this problem. In the context of utility of stem cells for tissue engineering,40 the
ATPS printing approach will be useful to determine niche conditions that result in optimum
differentiation levels of stem cells toward a particular lineage with minimal usage of precious stem
cells. The identification of niche size and colony interspacing effect on the efficiency of neuronal
differentiation of mESCs, which was discussed above, is an elucidating example.
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